These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 16930924

  • 41. Predictors and outcomes of linezolid-resistant vancomycin-resistant Enterococcus: a case-case-control study.
    Hayakawa K, Marchaim D, Pogue JM, Ho K, Parveen S, Nanjireddy P, Sunkara B, Singla M, Jagadeesh KK, Moshos JA, Bommarito S, Mroue R, Farhat M, Obeid T, Chaudhry A, Vadlamudi G, Lephart PR, Martin ET, Rybak MJ, Kaye KS.
    Am J Infect Control; 2012 Dec; 40(10):e261-3. PubMed ID: 23199727
    [Abstract] [Full Text] [Related]

  • 42. Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium.
    Herrero IA, Issa NC, Patel R.
    N Engl J Med; 2002 Mar 14; 346(11):867-9. PubMed ID: 11893808
    [No Abstract] [Full Text] [Related]

  • 43. Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
    Mave V, Garcia-Diaz J, Islam T, Hasbun R.
    J Antimicrob Chemother; 2009 Jul 14; 64(1):175-80. PubMed ID: 19423543
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers).
    Jones RN, Fritsche TR, Sader HS, Ross JE.
    Diagn Microbiol Infect Dis; 2007 Nov 14; 59(3):309-17. PubMed ID: 17720350
    [Abstract] [Full Text] [Related]

  • 47. Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin.
    Noskin GA, Siddiqui F, Stosor V, Kruzynski J, Peterson LR.
    Clin Infect Dis; 1999 Mar 14; 28(3):689-90. PubMed ID: 10194104
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Linezolid for the treatment of complicated skin and skin structure infections in children.
    Yogev R, Patterson LE, Kaplan SL, Adler S, Morfin MR, Martin A, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB.
    Pediatr Infect Dis J; 2003 Sep 14; 22(9 Suppl):S172-7. PubMed ID: 14520143
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Colonisation with vancomycin- and linezolid-resistant Enterococcus faecium in a university hospital: molecular epidemiology and risk factor analysis.
    Souli M, Sakka V, Galani I, Antoniadou A, Galani L, Siafakas N, Zerva L, Fytrou H, Tsiodras S, Giamarellou H.
    Int J Antimicrob Agents; 2009 Feb 14; 33(2):137-42. PubMed ID: 19013056
    [Abstract] [Full Text] [Related]

  • 52. In vitro susceptibility of Gram-positive pathogens to linezolid and teicoplanin and effect on outcome in critically ill patients.
    Wilson AP, Cepeda JA, Hayman S, Whitehouse T, Singer M, Bellingan G.
    J Antimicrob Chemother; 2006 Aug 14; 58(2):470-3. PubMed ID: 16735420
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. In vitro activity of fosfomycin tromethamine and linezolid against vancomycin-resistant Enterococcus faecium isolates.
    Cilli F, Pullukcu H, Aydemir S, Sipahi OR, Tasbakan M, Turhan A, Ulusoy S.
    Int J Antimicrob Agents; 2008 Mar 14; 31(3):297-8. PubMed ID: 18180144
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Invasive infections due to vancomycin-resistant enterococci in adult patients.
    Jean SS, Fang CT, Wang HK, Hsue PR, Chang SC, Luh KT.
    J Microbiol Immunol Infect; 2001 Dec 14; 34(4):281-6. PubMed ID: 11825009
    [Abstract] [Full Text] [Related]

  • 57. Pharmacodynamics of early, high-dose linezolid against vancomycin-resistant enterococci with elevated MICs and pre-existing genetic mutations.
    Tsuji BT, Bulitta JB, Brown T, Forrest A, Kelchlin PA, Holden PN, Peloquin CA, Skerlos L, Hanna D.
    J Antimicrob Chemother; 2012 Sep 14; 67(9):2182-90. PubMed ID: 22685161
    [Abstract] [Full Text] [Related]

  • 58. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study.
    Crank CW, Scheetz MH, Brielmaier B, Rose WE, Patel GP, Ritchie DJ, Segreti J.
    Clin Ther; 2010 Sep 14; 32(10):1713-9. PubMed ID: 21194593
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. [In vitro activity of linezolid and dalbavancin against vancomycin-resistant enterococci].
    Aktaş G, Bozdoğan B, Derbentli S.
    Mikrobiyol Bul; 2012 Jul 14; 46(3):359-65. PubMed ID: 22951648
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.